YOURx Health review

YOURx Health puts its prices in public, with no portal sign-up: sermorelin is $196 a month, NAD⁺ is $199 as a nasal spray and $225 as an injection, glutathione is $95, and a PT-141 troche starts at $99.99, all on one public treatments page you can read before giving anyone your history. That makes it easy to compare. Identity is the weak spot. No operating entity is named beyond the brand and a Beaumont, Texas footer, no compounding pharmacy is named, no state list exists, and no LegitScript, NABP or PCAB seal appears. You can compare its prices; you cannot check who it is.

YOURx Health is a compounded-medication telehealth platform running its clinical layer on the MD Integrations network, a recognized white-label provider platform used across the industry. Its treatments page carries a per-product price list spanning weight loss (compounded semaglutide injection $179/mo and tirzepatide injection $199/mo, plus rapid-dissolve oral tablets of each at $159 and $179), longevity and recovery (NAD+ injection $225/mo, NAD+ nasal spray $199/mo, sermorelin $196/mo, glutathione $95/mo, B12+MIC $99/mo) and sexual health (a PT-141, oxytocin and tadalafil troche starting at $99.99/mo). Everything is self-pay; its FAQ states it does not accept medical insurance.

Video-gated and vendor-run. The site describes a physician video consultation, medication delivery, regular check-ins, lab monitoring and refills, with medical care and prescriptions delivered through the MD Integrations network — naming the clinical platform vendor is a small transparency point in its favor, because MD Integrations is checkable even though the individual prescriber is not. Lab work is flagged as required for certain prescriptions, which for a growth-hormone-axis or hormone product is the right posture. From there the disclosures run out. The legal entity operating the site is not disclosed anywhere; the footer gives a Beaumont, Texas location and a brand copyright and nothing more. No compounding pharmacy partner is named. No state availability list is published, and the homepage coverage counter is an animated graphic rather than a stated number. No LegitScript, NABP .Pharmacy or PCAB accreditation is displayed — and on a site selling injectable prescriptions, the absence of all three at once is the single biggest gap here. Weigh the published price list against that: knowing what something costs is not the same as knowing who is making it.

The clearest thing about this platform. Sermorelin is listed at $196.00 per month and glutathione at $95.00 per month; NAD⁺ is priced by route at $199.00 for the nasal spray and $225.00 for the injection; the PT-141, oxytocin and tadalafil troche starts at $99.99 per month. Each is a flat per-product monthly figure with no stated dose ladder in either direction, so ask whether the price holds as your dose changes — the site says nothing either way. Everything is self-pay; the FAQ states verbatim that all products are available on a self-pay basis because it does not accept medical insurance at this time. For context only, the weight-loss line runs $179 and $199 a month for compounded semaglutide and tirzepatide injections and $159 and $179 for the oral rapid-dissolve tablets, with B12 included on the injections — but those are GLP-1 figures and neither is a sermorelin or NAD⁺ price. Two things the page does not tell you and you should ask: what the monthly shipment contains in milligrams, and whether the required lab work is billed separately from the medication.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The platform states its products are compounded and that prescriptions come through the MD Integrations clinician network, but it names no pharmacy, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, its four longevity products are not four equivalent purchases even though they sit in one price list. Sermorelin is a GHRH analog that stimulates your own pituitary rather than supplying growth hormone — a real, well-described mechanism whose long-term human outcome data stays thin beyond short-term IGF-1 movement. Injected and intranasal NAD⁺ have no controlled human outcome trials at all, and pricing the nasal spray below the injection reflects manufacturing cost rather than any comparative evidence; the NAD⁺ forms with human trial data are the oral precursors NR and NMN, which raise a blood level rather than demonstrate an outcome. Injectable glutathione has essentially no controlled human outcome data behind the antioxidant and skin claims made for it. PT-141 is the exception in the other direction — bremelanotide is FDA-approved for one narrow indication, generalized hypoactive sexual desire disorder in premenopausal women, so a compounded troche prescribed to anyone else is off-label use of an approved molecule, and combining it with tadalafil and oxytocin in a single preparation is a formulation no trial has studied. Individual results vary.